Induce Biologics Overview

  • Founded
  • 2008

Founded

  • Status
  • Out of Business

  • Employees
  • 8

Employees

  • Latest Deal Type
  • Out of Business

Induce Biologics General Information

Description

Manufacturer of bioimplants created to improve patients outcomes by providing cost-effective innovative solutions for bone regeneration. The company's products are used to optimize handling and efficient bone regeneration, enabling patients to reduce the need for a second surgery and improving healing times of patients through the use of URIST.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Therapeutic Devices
Primary Office
  • 180 Dundas Street West
  • Suite 1702
  • Toronto, Ontario M5G 1Z8
  • Canada

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Induce Biologics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Out of Business 01-Aug-2018 00.000 Completed Out of Business
4. Later Stage VC 01-Sep-2016 00.000 00.000 Completed Generating Revenue
3. Later Stage VC 01-Jan-2016 00.000 00.000 Completed Generating Revenue
2. Grant 01-Apr-2015 $23.8K $2M Completed Generating Revenue
1. Later Stage VC 27-Feb-2015 $2M $2M Completed Generating Revenue
To view Induce Biologics’s complete valuation and funding history, request access »

Induce Biologics Patents

Induce Biologics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2009200540-A1 Use of immobilized antagonists for enhancing growth factor containing bioimplant effectiveness Inactive 03-Jul-2008 00000000000
CA-2653866-A1 Use of immobilized antagonists for enhancing growth factor containing bioimplant effectiveness Inactive 03-Jul-2008 00000000000
EP-2310062-A1 Use of immobilized antagonists for enhancing growth factor containing bioimplant effectiveness Inactive 03-Jul-2008 00000000000
EP-2310062-A4 Use of immobilized antagonists for enhancing growth factor containing bioimplant effectiveness Inactive 03-Jul-2008 00000000000 0
US-20110182911-A1 Use of immobilized antagonists for enhancing growth factor containing bioimplant effectiveness Inactive 03-Jul-2008 A61K38/1841
To view Induce Biologics’s complete patent history, request access »

Induce Biologics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial